Evaluation of Convalescent Plasma in the Management of Critically Ill COVID-19 Patients (with No Detectable Neutralizing Antibodies Nab) in Kashmir, India

Background: For centuries, convalescent plasma (CP) has been recommended to treat a diverse set of viral diseases. Therefore, the present study was undertaken to evaluate the effectiveness of CP in critically ill COVID-19 patients. Methods and Materials: From 23 March 2021 to 29 December 2021, an op...

Descripción completa

Detalles Bibliográficos
Autores principales: Elkhalifa, Ahmed M. E., Nabi, Showkat Ul, Shah, Naveed Nazir, Dar, Khurshid Ahmad, Quibtiya, Syed, Bashir, Showkeen Muzamil, Ali, Sofi Imtiyaz, Taifa, Syed, Hussain, Iqra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9914564/
https://www.ncbi.nlm.nih.gov/pubmed/36766892
http://dx.doi.org/10.3390/healthcare11030317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9914564/
https://www.ncbi.nlm.nih.gov/pubmed/36766892
http://dx.doi.org/10.3390/healthcare11030317

Ejemplares similares